These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 33429150)

  • 21. Recent Discussions on Dopamine Supersensitivity Psychosis: Eight Points to Consider When Diagnosing Treatment-Resistant Schizophrenia.
    Kanahara N; Kimura H; Oda Y; Ito F; Iyo M
    Curr Neuropharmacol; 2021; 19(12):2214-2226. PubMed ID: 33550976
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antipsychotic Induced Dopamine Supersensitivity Psychosis: A Comprehensive Review.
    Yin J; Barr AM; Ramos-Miguel A; Procyshyn RM
    Curr Neuropharmacol; 2017; 15(1):174-183. PubMed ID: 27264948
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A prospective comparative study of risperidone long-acting injectable for treatment-resistant schizophrenia with dopamine supersensitivity psychosis.
    Kimura H; Kanahara N; Komatsu N; Ishige M; Muneoka K; Yoshimura M; Yamanaka H; Suzuki T; Komatsu H; Sasaki T; Hashimoto T; Hasegawa T; Shiina A; Ishikawa M; Sekine Y; Shiraishi T; Watanabe H; Shimizu E; Hashimoto K; Iyo M
    Schizophr Res; 2014 May; 155(1-3):52-8. PubMed ID: 24667073
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dopamine supersensitivity psychosis and dopamine partial agonist: a retrospective survey of failure of switching to aripiprazole in schizophrenia.
    Takase M; Kanahara N; Oda Y; Kimura H; Watanabe H; Iyo M
    J Psychopharmacol; 2015 Apr; 29(4):383-9. PubMed ID: 25735995
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma monoamines change under dopamine supersensitivity psychosis in patients with schizophrenia: A comparison with first-episode psychosis.
    Takase M; Kimura H; Kanahara N; Nakata Y; Iyo M
    J Psychopharmacol; 2020 May; 34(5):540-547. PubMed ID: 31961236
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dopamine supersensitivity psychosis as a pivotal factor in treatment-resistant schizophrenia.
    Suzuki T; Kanahara N; Yamanaka H; Takase M; Kimura H; Watanabe H; Iyo M
    Psychiatry Res; 2015 Jun; 227(2-3):278-82. PubMed ID: 25863824
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A randomized-controlled trial of blonanserin and olanzapine as adjunct to antipsychotics in the treatment of patients with schizophrenia and dopamine supersensitivity psychosis: The ROADS study.
    Niitsu T; Hata T; Nishimoto M; Hosoda Y; Kimura A; Oda Y; Suzuki M; Takase N; Seki R; Fujita K; Endo M; Yoshida T; Inoue M; Hattori N; Murakami T; Imamura Y; Ogawa K; Fukami G; Sato T; Kawasaki Y; Hashimoto T; Ishikawa M; Shiina A; Kanahara N; Iyo M;
    Asian J Psychiatr; 2020 Oct; 53():102369. PubMed ID: 32920492
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic association between G protein-coupled receptor kinase 6/β-arrestin 2 and dopamine supersensitivity psychosis in schizophrenia.
    Oda Y; Kanahara N; Kimura H; Watanabe H; Hashimoto K; Iyo M
    Neuropsychiatr Dis Treat; 2015; 11():1845-51. PubMed ID: 26251601
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antipsychotic-evoked dopamine supersensitivity.
    Servonnet A; Samaha AN
    Neuropharmacology; 2020 Feb; 163():107630. PubMed ID: 31077727
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Haloperidol-induced behavioral supersensitivity is increased by monosialoganglioside treatment in rats without affecting spiroperidol-binding.
    Schröder U; Schröder H; Augustin W; Sabel BA
    J Pharmacol Exp Ther; 1994 Dec; 271(3):1193-6. PubMed ID: 7996425
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alterations in striatal neuropeptide Y system activity of rats with haloperidol-induced behavioral supersensitivity.
    Obuchowicz E; Krysiak R; Wieronska JM; Smialowska M; Herman ZS
    Neuropeptides; 2005 Oct; 39(5):515-23. PubMed ID: 16154634
    [TBL] [Abstract][Full Text] [Related]  

  • 32. "Breakthrough" dopamine supersensitivity during ongoing antipsychotic treatment leads to treatment failure over time.
    Samaha AN; Seeman P; Stewart J; Rajabi H; Kapur S
    J Neurosci; 2007 Mar; 27(11):2979-86. PubMed ID: 17360921
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dopamine supersensitivity and D1/D2 synergism are unrelated to changes in striatal receptor density.
    LaHoste GJ; Marshall JF
    Synapse; 1992 Sep; 12(1):14-26. PubMed ID: 1357762
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risperidone long-acting injectable in the treatment of treatment-resistant schizophrenia with dopamine supersensitivity psychosis: Results of a 2-year prospective study, including an additional 1-year follow-up.
    Kimura H; Kanahara N; Sasaki T; Komatsu N; Ishige M; Muneoka K; Ino H; Yoshimura K; Yamanaka H; Suzuki T; Komatsu H; Watanabe H; Shimizu E; Iyo M
    J Psychopharmacol; 2016 Aug; 30(8):795-802. PubMed ID: 27371496
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Case series on aripiprazole and dopamine supersensitivity psychosis.
    Russell G; Reinfeld S; Kam O; Lee G; Weiss M; Koola MM
    Int Clin Psychopharmacol; 2022 May; 37(3):122-128. PubMed ID: 35143441
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dopamine D2 receptors as treatment targets in schizophrenia.
    Seeman P
    Clin Schizophr Relat Psychoses; 2010 Apr; 4(1):56-73. PubMed ID: 20643630
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clonazepam improves dopamine supersensitivity in a schizophrenia patient: a case report.
    Fukai M; Hirosawa T; Takahashi T; Kaneda R; Kikuchi M; Minabe Y
    Ther Adv Psychopharmacol; 2017 Mar; 7(3):113-117. PubMed ID: 28348731
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of clozapine on dopamine supersensitivity psychosis in schizophrenia.
    Nakata Y; Kanahara N; Kimura H; Watanabe H; Iyo M
    Int Clin Psychopharmacol; 2017 May; 32(3):169-173. PubMed ID: 28067751
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Opposite effects of low versus high dose haloperidol treatments on spontaneous and apomorphine induced motor behavior: evidence that at a very low dose haloperidol acts as an indirect dopamine agonist.
    Dias FR; de Matos LW; Sampaio Mde F; Carey RJ; Carrera MP
    Behav Brain Res; 2012 Apr; 229(1):153-9. PubMed ID: 22244923
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antipsychotic-induced supersensitivity - A reappraisal.
    Lugg W
    Aust N Z J Psychiatry; 2022 May; 56(5):437-444. PubMed ID: 34144649
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.